Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020838
Company: ANI PHARMS
Company: ANI PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ATACAND | CANDESARTAN CILEXETIL | 4MG | TABLET;ORAL | Prescription | AB | Yes | No |
ATACAND | CANDESARTAN CILEXETIL | 8MG | TABLET;ORAL | Prescription | AB | Yes | No |
ATACAND | CANDESARTAN CILEXETIL | 16MG | TABLET;ORAL | Prescription | AB | Yes | No |
ATACAND | CANDESARTAN CILEXETIL | 32MG | TABLET;ORAL | Prescription | AB | Yes | Yes |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
06/24/2020 | SUPPL-41 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020838s041lbl.pdf | |
02/09/2016 | SUPPL-39 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020838s039lbl.pdf | |
02/06/2015 | SUPPL-36 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020838s036lbl.pdf | |
04/26/2013 | SUPPL-38 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020838s038lbl.pdf | |
04/27/2012 | SUPPL-35 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020838s035lbl.pdf | |
04/13/2012 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020838s032lbl.pdf | |
06/24/2011 | SUPPL-33 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020838s033lbl.pdf | |
10/22/2009 | SUPPL-31 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020838s031lbl.pdf | |
08/17/2006 | SUPPL-26 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020838s026lbl.pdf | |
05/18/2005 | SUPPL-22 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020838s022lbl.pdf | |
02/22/2005 | SUPPL-24 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20838s024lbl.pdf | |
09/13/2002 | SUPPL-15 | Efficacy-Accelerated Approval Confirmatory Study | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20838s015lbl.pdf | |
06/04/1998 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20838lbl.pdf |